SEC Comment Letter 0000000000-24-011045 to Akso Health Group (AHG)

Akso Health Group
Date: Sept. 30, 2024 · CIK: 0001702318 · Accession: 0000000000-24-011045

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38245

Date

September 30, 2024

Author

Linda Wang

Form

UPLOAD

Company

Akso Health Group

Letter

September 30, 2024 Linda Wang Chief Executive Officer Akso Health Group Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building No. 44, Moscow Road , Qianwan Bonded Port Area Qingdao Pilot Free Trade Zone, China (Shandong) Re:Akso Health Group Form 20-F for the Fiscal Year Ended March 31, 2023 Form 20-F for the Fiscal Year Ended March 31, 2024 File No. 001-38245 Dear Linda Wang: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Trade & Services

Show Raw Text

September 30, 2024
Linda Wang
Chief Executive Officer
Akso Health Group
Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building
No. 44, Moscow Road , Qianwan Bonded Port Area
Qingdao Pilot Free Trade Zone, China (Shandong)
Re:Akso Health Group
Form 20-F for the Fiscal Year Ended March 31, 2023
Form 20-F for the Fiscal Year Ended March 31, 2024
File No. 001-38245
Dear Linda Wang:
            We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Trade & Services

SecProbe.io